T cell growth factor
    11.
    发明授权
    T cell growth factor 失效
    T细胞生长因子

    公开(公告)号:US5587302A

    公开(公告)日:1996-12-24

    申请号:US462158

    申请日:1990-01-08

    摘要: The present invention relates generally to a T cell growth factor. More particularly, the present invention relates to a T cell growth factor which comprises a glycoprotein which supports interleukin 2- and interleukin 4-independent growth of helper T cells especially from murine and human sources and further which is capable of augmenting proliferation of IL3- or IL4-responsive cells. Even more particularly, the present invention relates to the helper T cell growth factor P40, pharmaceutical compositions thereof, antibodies thereto and recombinant DNA clones thereof. The present invention also contemplates a method for inducing the proliferation of helper T cells as well as IL3- and Il4-responsive cells. The helper T cells growth factor contemplated herein is useful in the stimulation of specific cells in the immune system, either alone or in combination with IL3 or IL4.

    摘要翻译: 本发明一般涉及T细胞生长因子。 更具体地,本发明涉及一种T细胞生长因子,其包含支持辅助性T细胞的白细胞介素2-和白细胞介素4非依赖性生长的糖蛋白,特别是来自鼠源和人来源,并且还能够增强IL3-或 IL4反应细胞。 更具体地,本发明涉及辅助性T细胞生长因子P40,其药物组合物,其抗体及其重组DNA克隆。 本发明还考虑了一种诱导辅助性T细胞以及IL3和II4反应性细胞增殖的方法。 本文考虑的辅助T细胞生长因子可用于单独或与IL3或IL4组合在免疫系统中刺激特异性细胞。

    Process for preparing mammalian T cell growth factor P40
    13.
    发明授权
    Process for preparing mammalian T cell growth factor P40 失效
    制备哺乳动物T细胞生长因子P40的方法

    公开(公告)号:US5750377A

    公开(公告)日:1998-05-12

    申请号:US447805

    申请日:1995-05-23

    摘要: The present invention relates generally to a T cell growth factor. More particularly, the present invention relates to a T cell growth factor which comprises a glycoprotein which supports interleukin 2- and interleukin 4-independent growth of helper T cells especially from murine and human sources and further which is capable of augmenting proliferation of IL3- or IL4-responsive cells. Even more particularly, the present invention relates to the helper T cell growth factor P40, pharmaceutical compositions thereof, antibodies thereto and recombinant DNA clones thereof. The present invention also contemplates a method for inducing the proliferation of helper T cells as well as IL3- and Il4-responsive cells. The helper T cells growth factor contemplated herein is useful in the stimulation of specific cells in the immune system, either alone or in combination with IL3 or IL4.

    摘要翻译: 本发明一般涉及T细胞生长因子。 更具体地,本发明涉及一种T细胞生长因子,其包含支持辅助性T细胞的白细胞介素2-和白细胞介素4非依赖性生长的糖蛋白,特别是来自鼠源和人来源,并且还能够增强IL3-或 IL4反应细胞。 更具体地,本发明涉及辅助性T细胞生长因子P40,其药物组合物,其抗体及其重组DNA克隆。 本发明还考虑了一种诱导辅助性T细胞以及IL3和II4反应性细胞增殖的方法。 本文考虑的辅助T细胞生长因子可用于单独或与IL3或IL4组合在免疫系统中刺激特异性细胞。

    Adjuvant compositions for vaccines
    15.
    发明授权
    Adjuvant compositions for vaccines 失效
    疫苗佐剂组合物

    公开(公告)号:US06375945B1

    公开(公告)日:2002-04-23

    申请号:US09445841

    申请日:2000-02-08

    IPC分类号: A61K3819

    摘要: The present invention pertains to improved adjuvant compositions comprising a mixture of a saponin adjuvant such as QS21 with monophosphoryl lipid A or derivative thereof such as 3D-MPL and interleukin 12. These compositions are useful in a range of prophylactic and therapeutic applications, particularly in vaccines, including cancer vaccines.

    摘要翻译: 本发明涉及包含皂苷佐剂如QS21与单磷酰脂质A或其衍生物如3D-MPL和白细胞介素12的混合物的改进的佐剂组合物。这些组合物可用于一系列预防和治疗应用,特别是在疫苗中 ,包括癌症疫苗。